Initial thrombolysis treatment compared with anticoagulation for acute intermediate-risk pulmonary embolism: a meta-analysis.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 4454855)

Published in J Thorac Dis on May 01, 2015

Authors

Qixia Xu1, Ke Huang1, Zhenguo Zhai1, Yuanhua Yang1, Jun Wang1, Chen Wang1

Author Affiliations

1: 1 Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China ; 2 Beijing Key Laboratory of Respiratory and Pulmonary Circulation Disorders, Beijing 100069, China ; 3 Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China ; 4 Department of Respiratory and Critical Care Medicine, China-Japan Friendship Hospital, Peking University Health Science Center, Beijing 100029, China ; 5 Department of Physiology, School of Basic Medical Science, Capital Medical University, Beijing 100069, China ; 6 Department of Respiratory Medicine, Capital Medical University, Beijing 100069, China ; 7 China-Japan Friendship Hospital, Beijing 100029, China.

Articles citing this

Systemic Thrombolysis for Pulmonary Embolism: A Review. P T (2016) 0.75

Articles cited by this

Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J (2008) 12.31

Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med (2014) 9.33

Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med (2002) 8.28

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.57

Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation (2011) 5.16

Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA (2014) 4.49

Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost (2007) 4.09

Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost (2007) 3.67

Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism: results of a multicenter registry. Circulation (1997) 3.58

Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest (2009) 3.23

Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. Circulation (2004) 2.69

Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial). Am J Cardiol (2012) 2.55

Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet (1993) 2.12

Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation (2013) 2.08

Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. Chest (2009) 1.94

Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thromb Res (2009) 1.72

Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry. Chest (2001) 1.59

Thrombolytic therapy for patients with pulmonary embolism who are hemodynamically stable but have right ventricular dysfunction: pro. Arch Intern Med (2005) 1.53

Counterpoint: should systemic lytic therapy be used for submassive pulmonary embolism? No. Chest (2013) 1.49

Point: should systemic lytic therapy be used for submassive pulmonary embolism? Yes. Chest (2013) 1.46

Venous thromboembolism: epidemiology and magnitude of the problem. Best Pract Res Clin Haematol (2012) 1.27

Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost (2014) 1.08

Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. Am J Med Sci (2011) 0.98

Thrombolytic therapy for pulmonary embolism. Cochrane Database Syst Rev (2009) 0.92

Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. Am Heart J (1997) 0.92

Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis. Thromb Res (2013) 0.88

Management of massive and nonmassive pulmonary embolism. Arch Med Sci (2012) 0.84

Thrombolysis for pulmonary embolism in patients with right ventricular dysfunction: con. Arch Intern Med (2005) 0.84

Thrombolysis is not warranted in submassive pulmonary embolism: a systematic review and meta-analysis. Crit Care Resusc (2007) 0.83

Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort. Thromb J (2013) 0.82

Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis. J Thromb Haemost (2014) 0.82

Effectiveness and cost-effectiveness of thrombolysis in submassive pulmonary embolism. Arch Intern Med (2007) 0.82

Evidence-based emergency medicine/critically appraised topic. Thrombolytic therapy for submassive pulmonary embolism? Ann Emerg Med (2007) 0.81

Thrombolytic and anticoagulant therapy for acute submassive pulmonary embolism. Exp Ther Med (2013) 0.79

Systematic review and meta-analysis for thrombolysis treatment in patients with acute submassive pulmonary embolism. Patient Prefer Adherence (2014) 0.78

Management of massive and submassive pulmonary embolism. Am J Ther (2013) 0.77